Regulatory

The petition asks FDA to reverse its decision that NMN is not a dietary ingredient, and to exercise enforcement discrection.

Newly introduced legislation in Idaho (House Bill 82) ensures that dietary supplements that are in compliance with federal law and regulations as of July 1, 2022, shall be legal in the state in spite of any amendment, repeal or addition made to federal law or regulation of dietary supplements federally.

Following the merger of ESHA Research and FoodLogiQ in October 2022, the combined organization has rebranded under the name Trustwell.

Extraction solvent made entirely from plant-based carbon, methyloxolane, sold under the brand name EcoXtract, has been added to the list of permitted processing aids for the manufacture of food ingredients by the European Parliament.

The president of Nuherbs has released a statement about the listing of all Rhodiola species in the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) appendix II.

Amazon is banning the sale of beta-nicotinamide mononucleotide (NMN) products, according to a letter from Amazon’s Restricted Products Team furnished by the Natural Products Association.

FDA issued a “no questions letter” responding to DSM’s GRAS notification, while Australia’s Therapeutic Goods Administration included 3-FL in the latest update to its list of permissible ingredients.

The Federal Trade Commission (FTC) has charged The Bountiful Company, maker of Nature’s Bounty dietary supplements, with “review hijacking.”

THC acetate ester (THCO) is considered a controlled substance by the DEA but delta-8 THC derived from hemp is not considered a controlled substance.

CBD is an established product that is paving the way for other hemp-derived cannabinoids. However, regulation remains a big if for the category.

The U.S. Food and Drug Administration has reached the conclusion that “a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”

FDA warning letters in 2022 remind cardiovascular product companies about what they should and shouldn’t do in 2023.

FermentIQ is designed to improve the sensory, functional, and nutritional attributes of plant protein, the company says.

Astrion is a combination of Centella asiatica and Astragalus membranaceus that the company says has been clinically shown to support skin health.

David Murray, the director of the Office of Disease Prevention at the National Institutes of Health, is currently serving as the acting director of the Office of Dietary Supplements (ODS) until a new, permanent ODS director is selected.

Nutritional Outlook’s Editorial Advisory Board shares its predictions and tips for success in 2023.

FDA’s final guidance outlines how importers should comply with FSVP requirements, including those for importers of dietary supplements.

New York Governor Kathy Hochul has vetoed Assembly Bill 431-C, which would restrict minors from purchasing weight management and muscle building dietary supplements without a prescription.

The Council for Responsible Nutrition has issued a statement expressing disappointment at the exclusion of a mandatory product listing provision from the recently passed omnibus spending package. However, the association sees its passage as inevitable.

The listing for galactooligosaccharides in the European Union’s list of Novel Foods now mentions Foods for Special Medical Purposes (FSMPs).

The 2023 Omnibus Appropriations bill, a $1.7 trillion government funding package was released early on Tuesday, December 20, 2022 without a mandatory product listing provision.

The Council for Responsible Nutrition has issued a statement responding to claims made by the Natural Products Association on social media and other platforms related to mandatory product listing legislation, CRN’s support of MPL, and Senator Richard Durbin’s (D-IL) relationship to the dietary supplement industry.

With the bill awaiting Governor Hochul's signature, NPA sends request for veto. Similar NJ bill was up for a vote in the Assembly, but was pulled following concerns raised by NJ Department of Health.

Leading industry attorneys dig into the complexities of FDA’s announcement.

Given the interest in reviewing and considering amendments to several provisions of FD&C that would affect dietary supplements, AHPA believes strongly that these amendments should be addressed collectively in the 118th Congress. That way, stakeholders can fully engage with Congress.

Sebastian Krawiec, editor of Nutritional Outlook, talked to Daniel Fabricant, president and CEO of the Natural Products Association about a recent Marist Poll sponsored by the organization, and regulatory priorities.

Sebastian Krawiec, editor of Nutritional Outlook talks to Steve Mister, president and CEO of the Council for Responsible Nutrition about the organization’s recent consumer survey and its regulatory priorities before the close of the legislative session and beyond.

PeptiStrong contains natural peptides derived from fava bean.